Friday, July 22, 2016
Altruism has more of an evolutionary advantage than selfishness. Scientists say they have proved that doing good things for no personal gain can have an evolutionary advantage in the long run. Altruism is real and developed because it confers an evolutionary advantage that is ultimately greater than the benefits of selfishness, an international team of mathematicians claims to have proved.
Dr Tim Rogers, a co-author of a paper about the new research published in the Proceedings of the National Academy of Sciences journal, said:
“If you have two groups of people, one of whom was very altruistic and another group that was more selfish, it’s the altruistic, more social guys, who are better able to survive the bad winter or the drought…But if it’s always better to cheat, why doesn’t everybody cheat? The answer is it brings you bad luck, in a sense…altruistic behaviour is favoured by chance when the benefits of cheating are sufficiently small compared to a, how well the population would do without any cheats, and b, the typical size of random fluctuations in the population.”
The paper could have significant real-world implications.
“Our research suggests if society goes down a more selfish route, then it’s going to be less able to do well and survive the harsh realities of the world we live in,” Dr Rogers said. “Take the behaviour of the banks leading up to the [2008 financial] crisis … people were able to cash in on bad decisions before the big event that triggered the crash in the system.” The bankers were partly influenced by the desire to get annual bonuses. “That short-term thinking means they are not exposed yet to the random fluctuations that would drive the increase in altruism,” Dr Rogers said. He pointed to a suggestion that it might be better if bankers’ bonuses were delayed by a number of years and said this could “help even out that sense of taking really short-term, instantaneous gains” and promote more responsible behaviour.
Tuesday, July 05, 2016
Prof Neil Gow, from the University of Aberdeen, said "Most people know about mild fungal infections, but nobody's ever died from athlete's foot. However, a million people die a year from fungal infections”
Fungal infections kill more people than malaria or breast cancer but are not considered a priority. There are no vaccines and there is a "pressing need" for new treatments.
There are more than five million types of fungi, but only three major groups cause the majority of deaths in people:
Aspergillus - which affects the lungs
Cryptococcus - which mainly attacks the brain
Candida - which infects mucosal membranes including in the mouth and genitals
A new strain of Candida auris infection was first detected in 2009 in Japan, but has since been discovered across Asia and parts of south America. Public Health England said "Candida auris appears to be unlike other pathogenic yeast species in its propensity for transmission between hospital patients" and warned it was resistant to the first choice anti-fungal drugs, fluconazole, amphotericin B and caspofungin. U.S. public health officials are urging doctors and nurses to be on the lookout for the dangerous pathogen, which can be fatal in 30 percent to 60 percent of infected patients. Common yeast infections can be identified through conventional testing, but the specialized, molecular detection methods necessary for identifying C. auris are not available to all hospitals.